Dark Reading
Verdict
Oliver Tavakoli, chief technology officer at cybersecurity firm Vectra, compares Neuralink’s potential to change our bodies to gene-editing tool CRISPR, in that both “can be good and for evil”.
Latest T-Mobile Data Breach Has Some Wondering ‘How Lapsus$ Got Access in the First Place’
Channel Futures